500 Companies Show Interest In Hyderabad Pharma City

Hyderabad : The Hyderabad Pharma City (HPC), the flagship pharma park being developed by the Telangana Government, has been drawing enthusiastic response from the industry.

“So far, about 500 pharma and life sciences companies have expressed interest in setting up facilities in the upcoming city,’‘ a senior official of the Telangana State Industrial Infrastructure Corporation ((TSIIC) told businessline on Thursday.

HPC is proposed to be developed as the world’s largest integrated cluster in Hyderabad for pharmaceutical industries, thrusting on R&D and manufacturing and is expected to attract investments to the tune of $10 billion.

All domestic and global pharma majors are ready to set up their units in the pharma city coming up at about 25 km from Shamshabad airport, the official said, adding: “The entire land acquisition for the project has been completed.’‘

While the Government was keen on launching the project formally a few months ago, a small part of the land acquired got into legal issues and the matter is pending before the High Court now. “The matter is subjudice now. We can’t say more. However, we will proceed with allotment of land in HPC for the manufacturers immediately after the matter is resolved,’‘ he said.

According to the Government data, the life sciences sector in Telangana attracted ₹6,400 crore investment from 215 companies in 2021-22 which was 200 per cent more than the investment attracted by the industry at ₹2,766 crore from about 150 companies in FY21. The data for FY23 is yet to be released.

Related Posts

  • Pharma
  • July 27, 2024
  • 6 views
Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mumbai: Mankind Pharma on Thursday said it has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for…

  • Pharma
  • July 27, 2024
  • 42 views
Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Canberra: Mayne Pharma has filed a lawsuit against Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards